Lonza
Daniel González has an extensive background in quality assurance, translation, and localization, currently serving as Manager of QA and Quality Systems at Lonza since November 2021. In addition, Daniel has held the role of Business Development & Marketing Manager at MPS Translations since March 2017, where expertise in the healthcare industry and regulatory affairs is applied to develop B2B relationships and oversee global operations. Prior experience includes leadership positions at orangeglobal medical globalisation provider GmbH and Alpha CRC, focusing on project management for major medical and pharmaceutical companies. Daniel's education includes a Magister in German Studies from Universidad de Valladolid, an MBA in Pharmaceutical Marketing and Management from Universidad Católica de Ávila, and additional studies in Business Communications at The University of British Columbia.
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.